These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27126975)

  • 1. Effect of FTY720 (fingolimod) on graft survival in renal transplant recipients: a systematic review protocol.
    Gholamnezhadjafari R; Falak R; Tajik N; Aflatoonian R; Ali Keshtkar A; Rezaei A
    BMJ Open; 2016 Apr; 6(4):e010114. PubMed ID: 27126975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats.
    Ueda H; Takahara S; Azuma H; Kusaka M; Suzuki S; Katsuoka Y
    Eur Surg Res; 2000; 32(5):279-83. PubMed ID: 11111172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
    Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid avoidance or withdrawal for kidney transplant recipients.
    Pascual J; Zamora J; Galeano C; Royuela A; Quereda C
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005632. PubMed ID: 19160257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin use on graft and patient survival in kidney transplant recipients with type 2 diabetes: a systematic review protocol.
    Shamshad F; Tungsanga S; Senior P; Shojai S; Ghimire A; Ye F; Kung JY; Hariramani VK; Abdulrahman A; Penney M; Sultana N; Muneer S; Okpechi I; Bello AK
    BMJ Open; 2024 May; 14(5):e078393. PubMed ID: 38760033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
    Knight SR; Russell NK; Barcena L; Morris PJ
    Transplantation; 2009 Mar; 87(6):785-94. PubMed ID: 19300178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.
    Tedesco-Silva H; Pescovitz MD; Cibrik D; Rees MA; Mulgaonkar S; Kahan BD; Gugliuzza KK; Rajagopalan PR; Esmeraldo Rde M; Lord H; Salvadori M; Slade JM;
    Transplantation; 2006 Dec; 82(12):1689-97. PubMed ID: 17198261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study.
    Tedesco-Silva H; Lorber MI; Foster CE; Sollinger HW; Mendez R; Carvalho DB; Shapiro R; Rajagopalan PR; Mayer H; Slade J; Kahan BD;
    Clin Transplant; 2009; 23(5):589-99. PubMed ID: 19719728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Statins on Patients and Graft Survival in Kidney Transplant Recipients: a Survival Meta-analysis.
    Rostami Z; Moteshaker Arani M; Salesi M; Safiabadi M; Einollahi B
    Iran J Kidney Dis; 2017 Oct; 11(5):329-338. PubMed ID: 29038386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis.
    Lo P; Sharma A; Craig JC; Wyburn K; Lim W; Chapman JR; Palmer SC; Strippoli GF; Wong G
    Transplantation; 2016 Apr; 100(4):933-42. PubMed ID: 26425876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients.
    Goring SM; Levy AR; Ghement I; Kalsekar A; Eyawo O; L'Italien GJ; Kasiske B
    Curr Med Res Opin; 2014 Aug; 30(8):1473-87. PubMed ID: 24628478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study.
    Hoitsma AJ; Woodle ES; Abramowicz D; Proot P; Vanrenterghem Y;
    Nephrol Dial Transplant; 2011 Nov; 26(11):3802-5. PubMed ID: 21911597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection.
    Koch M; Poehnert D; Nashan B
    Transpl Immunol; 2016 Mar; 35():12-7. PubMed ID: 26802360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Mycophenolate Mofetil Dose Reduction on Allograft Outcomes in Kidney Transplant Recipients on Tacrolimus-Based Regimens: A Systematic Review.
    Su VCh; Greanya ED; Ensom MH
    Ann Pharmacother; 2011 Feb; 45(2):248-57. PubMed ID: 21304036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-adherence to immunosuppressants following renal transplantation: a protocol for a systematic review.
    Hucker A; Bunn F; Carpenter L; Lawrence C; Farrington K; Sharma S
    BMJ Open; 2017 Sep; 7(9):e015411. PubMed ID: 28963283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
    Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
    Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.
    Morgan RD; O'Callaghan JM; Knight SR; Morris PJ
    Transplantation; 2012 Jun; 93(12):1179-88. PubMed ID: 22660659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.
    Dragun D; Böhler T; Nieminen-Kelhä M; Waiser J; Schneider W; Haller H; Luft FC; Budde K; Neumayer HH
    Kidney Int; 2004 Mar; 65(3):1076-83. PubMed ID: 14871428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.
    Mayer K; Birnbaum F; Reinhard T; Reis A; Braunstein S; Claas F; Sundmacher R
    Br J Ophthalmol; 2004 Jul; 88(7):915-9. PubMed ID: 15205237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.